These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 20645833

  • 21. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
    Mohanam S, Jasti SL, Kondraganti SR, Chandrasekar N, Kin Y, Fuller GN, Lakka SS, Kyritsis AP, Dinh DH, Olivero WC, Gujrati M, Yung WK, Rao JS.
    Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835
    [Abstract] [Full Text] [Related]

  • 22. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas.
    Bolon I, Gouyer V, Devouassoux M, Vandenbunder B, Wernert N, Moro D, Brambilla C, Brambilla E.
    Am J Pathol; 1995 Nov; 147(5):1298-310. PubMed ID: 7485393
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
    Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4140-9. PubMed ID: 15217951
    [Abstract] [Full Text] [Related]

  • 24. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
    Davidson B, Reich R, Goldberg I, Gotlieb WH, Kopolovic J, Berner A, Ben-Baruch G, Bryne M, Nesland JM.
    Clin Cancer Res; 2001 Mar 15; 7(3):551-7. PubMed ID: 11297247
    [Abstract] [Full Text] [Related]

  • 25. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A, Scarlett CJ, Jackson CJ, Allen BJ, Smith RC.
    Pancreas; 2008 Mar 15; 36(2):160-7. PubMed ID: 18376307
    [Abstract] [Full Text] [Related]

  • 26. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells.
    Whitley BR, Palmieri D, Twerdi CD, Church FC.
    Exp Cell Res; 2004 Jun 10; 296(2):151-62. PubMed ID: 15149846
    [Abstract] [Full Text] [Related]

  • 27. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
    Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA, Wells A.
    Exp Cell Res; 2004 Sep 10; 299(1):91-100. PubMed ID: 15302576
    [Abstract] [Full Text] [Related]

  • 28. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X, Wang S, Zhou J, Xing H, Xu G, Wang B, Chen G, Lu YP, Ma D.
    Oncol Rep; 2005 Jul 10; 14(1):275-9. PubMed ID: 15944801
    [Abstract] [Full Text] [Related]

  • 29. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 30. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
    Whitley BR, Church FC.
    Int J Oncol; 2005 Sep 01; 27(3):749-57. PubMed ID: 16077925
    [Abstract] [Full Text] [Related]

  • 31. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 32. Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells.
    Peverali FA, Mandriota SJ, Ciana P, Marelli R, Quax P, Rifkin DB, Della Valle G, Mignatti P.
    J Cell Physiol; 1994 Oct 20; 161(1):1-14. PubMed ID: 7523424
    [Abstract] [Full Text] [Related]

  • 33. Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion.
    Mazumdar A, Adam L, Boyd D, Kumar R.
    Cancer Res; 2001 Jan 01; 61(1):400-5. PubMed ID: 11196194
    [Abstract] [Full Text] [Related]

  • 34. [The effect of basic fibroblast growth factor in ovarian cancer growth and angiogenesis].
    Lin W, Peng ZL, Zheng A, Bi JH, Huang ZY.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec 01; 20(6):532-5. PubMed ID: 14669225
    [Abstract] [Full Text] [Related]

  • 35. [Effects of follicle stimulating hormone on proliferation, apoptosis, migration and invasion of ovarian carcinoma cells: an in vitro experiment].
    Huang Y, Zhao YQ, Su M, Gao SJ, Jin HY, Feng YJ.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 18; 87(35):2512-4. PubMed ID: 18067819
    [Abstract] [Full Text] [Related]

  • 36. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.
    Kim KR, Yoshizaki T, Miyamori H, Hasegawa K, Horikawa T, Furukawa M, Harada S, Seiki M, Sato H.
    Oncogene; 2000 Mar 30; 19(14):1764-71. PubMed ID: 10777210
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Relationship between cathepsin L and invasion and metastasis of ovarian carcinoma cells].
    Wang SM, Li L, Zhang W, Li DR, Tang BJ.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug 30; 45(8):598-602. PubMed ID: 21029616
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.